Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies and Aplastic Anaemia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antithymocyte globulin; Cyclophosphamide; Fludarabine; Methotrexate; Methylprednisolone; Mycophenolate mofetil; Sargramostim; Tacrolimus
- Indications Graft-versus-host disease; Haematological malignancies
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2020 Biomarkers information updated
- 18 Sep 2012 Planned end date changed from 1 Oct 2009 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 22 Feb 2011 Planned end date changed from 1 Oct 2010 to 1 Oct 2009 as reported by ClinicalTrials.gov.